top of page

A bocca aperta

Quante volte mi sono chiesto perché fatti da tempo conosciuti all’estero qui in Italia sembrassero come inesistenti. Quante volte mi sono chiesto ad esempio come mai si continuasse a fare le lastre per la displasia dell’anca con un sistema impreciso mai validato dalla scienza quando invece se ne sarebbe potuto adottare uno che lo è (Pennhip).A sorpresa questa estate leggendo il libro “Vaccini Danni e Bugie” ho trovato una risposta non composta da illazioni e cattiverie varie ma da fatti reali incontrovertibili. Così nel primo capitolo “Gli interessi economici” trovo delle informazioni che superano le mie più esagerate fantasie sul perché di tanta ignoranza.

Leggo infatti che nel 2010  il Dott. Fulvio Stanga (Scivac) ha dichiarato che Sivae (Società italiana veterinari per animali esotici), Sivar (Società italiana veterinari animali da reddito) Sive (Società italiana veterinari per equini) e Scivac (Società culturale italiana veterinari animali da compagnia) hanno rinunciato ai  crediti -*ECM  (Educazione continua in medicina). Ovvero è un sistema attraverso il quale  il veterinario  si aggiorna per rispondere ai bisogni dei pazienti, e al  proprio sviluppo professionale!

E sapete perché ciò è avvenuto? Sedetevi, capirete tra un attimo il perché! La rinuncia è stata così spiegata dal Dott. Stanga: “Tutti i migliori relatori a livello internazionale hanno, bene o male, per motivi di ricerca o sviluppo di progetti scientifici, rapporti con aziende del settore”.

Perdindirindinaaaaaa! Questo secondo gli autori (Stefano Cattinelli-Silia Maruncelli)sta a dire  e cito:” Questo significa che tutti quei veterinari (americani o europei)che possiedono le conoscenze, e che quindi hanno qualcosa da insegnare ai veterinari italiani, sono legati, in un modo o in un altro, alle aziende farmaceutiche o mangimistiche. Tale collegamento rende di fatto impossibile il loro utilizzo all’interno dei progetti di educazione continua in medicina e quindi obbliga

l’Anmvi e la Scivac (che sono i principali organizzatori di convegni di aggiornamento per i veterinari in Italia) a rinunciare agli *ECM, poiché è praticamente impossibile trovare relatori non legati alle industrie (conflitto di interessi). Purtroppo anche la letteratura scientifica, attraverso la pubblicazione di studi e ricerche, è fortemente influenzata da questi conflitti d’interesse per fare qualunque ricerca c’è bisogno di cospicui finanziamenti e chi pensate che abbia la capacità economica di erogarli?!

Così ci siamo andati a guardare l’articolo di Gayle DeLong, docente al dipartimento di Economia e finanza del Baruch College di New York, in un articolo pubblicato nel 2012.

Conflicts of Interest in Vaccine Safety Research

https://www.researchgate.net/profile/Gayle_Delong/publication/221871714_Conflicts_of_Interest_in_Vaccine_Safety_Research/links/559064f408ae1e1f9bae1b21.pdf?origin=publication_detail

​

​

​

Abstract

Conflicts of interest (COIs) cloud vaccine safety research. Sponsors of research have competing interests that may impede the objective study of vaccine side effects. Vaccine manufacturers, health officials, and medical journals may have financial and bureaucratic reasons for not wanting to acknowledge the risks of vaccines. Conversely, some advocacy groups may have legislative and financial reasons to sponsor research that finds risks in vaccines. Using the vaccine-autism debate as an illustration, this article details the conflicts of interest each of these groups faces, outlines the current state of vaccine safety research, and suggests remedies to address COIs. Minimizing COIs in vaccine safety research could reduce research bias and restore greater trust in the vaccine program.

Although post licensure analyses are typically undertaken to ensure the safety of the products,

such analyses in the United States, for example, are

performed by the same regulatory agencies that initially approved the vaccines (Salmon et al., 2004).

Moreover, vaccine manufacturers do not face the threat of lawsuits that might motivate other industries to seek to improve safety.

The National Childhood Vaccine Injury Act of 1986 protects vaccine companies in the United States from being sued.

​

Ma se non bastasse c’è una lettera del Dr. M.W.Fox alla British Veterinary Association ed All’Editor,
Journal of the American Veterinary Medical Association,
Sent via e-mail May 26, 2009

​

Dear Sir,

EXAMINING CONFLICTS OF INTEREST IN THE VETERINARY PROFESSION

​

The relationships between the corporate sector, and in particular with drug companies, and private medical practitioners, hospitals, and medical schools, are being called to question by the Institute of Medicine in the US (1).

Is a similar examination called for in the veterinary sector where comparable corporate interests may be at play and affect the quality of care and services animal patients receive? It would seem that there has been a lack of due diligence over the role of diet, specifically, highly processed pet foods (2) in many contemporary health problems of companion animals. The same may be said about the routine application and so called “preventive” treatments with anti-flea and tick topical products that only now are being fully evaluated by the Environmental Protection Agency (3). Was due diligence also lacking, in part because of inadequate information and understanding, with dog and cat vaccinations? Until recently the universal protocol of giving dogs and cats annual “booster” injections of multivalent live and genetically engineered vaccines met resistance when ever questioned.

Corporate sector partnering in academia even includes chairs and professorships named after the donating company at many veterinary colleges. What role such partnering may play in contributing to the grave consequences of poor diets, over-medication, and hyperimmunization in companion animals by deferring to vested interests and by claiming lack of scientific proof of harm from such practices, is an open question. Academia should not be exploited to garner public credibility, nor should the market place become the final arbiter of what is acceptable.

Examining possible conflicts of interest may be difficult, considering the partnership of the American Veterinary Medical Association with Fort Dodge and Merial pharmaceutical companies, and Hill’s Pet Nutrition, who together have pledged $4.5 million in support of AVMA programs and services over the next four years (4). But this difficulty could become a confluence of interests once the health and well-being of companion animals are first and foremost on the agenda. The content of both the JAVMA, and its equivalent with the British Veterinary Association’s (BVA) Veterinary Record, increasingly addresses issues concerning animal health and welfare, including nutrition and vaccinations.

In the UK, the government and the BVA have chosen to focus on the health and welfare problems of a genetic origin, primarily in pedigree dogs. Some critics believe that this is a massive displacement, since it is the genetic susceptibilities to dietary diseases and vaccinoses (adverse vaccination reactions) in specific breeds make them the canaries for the canine population at large (5). The appropriate use of vaccines, (6), various “preventive” veterinary drugs, prescription diets, and the adequacies of manufactured cat and dog foods, also need to be considered if the mandate of the British government is to protect the health and welfare of companion and other animals, not just better regulate breeding practices. British dog breeders feel they are the scapegoats and are taking all the blame for the myriad and costly health problems in today’s canine population. The same can be said for the major ailments in the feline population, where poor diets and adverse drug and vaccine reactions similarly take their toll according to Hill’s former Director of Technical Affairs, veterinarian Dr. Elizabeth Hodgkins Esq.(7)

Of course there are confluences of interest that can benefit all and this would be forthcoming I believe when there is a more integrated approach to animal health and welfare. This could be developed from a bioethical basis (8) by veterinary teachers, researchers and practitioners, a Council for Veterinary Bioethics being one response to the call for an examination of possible conflicts of interest within the profession.I did not even receive an acknowledgement from the British Veterinary Association, while the Interim Editor-in-Chief of the Journal of the American Veterinary Medical Association, which usually publishes my letters, sent me the following letter via regular mail, dated May 28, 2009:

​

​

E questa la esilarante risposta!

Dear Dr. Fox,

Thank you for your recent letter to the editor. Although corporate influences on quality of care in the human and veterinary medical professions are important concerns, I am afraid that your letter attempts to address too many of these issues in too limited a space. Topics such as the effects of processed pet foods on the health of companion animals, annual vaccination of dogs and cats, corporate sponsorship of academic chairs and professorships, and the British Veterinary Association’s focus on genetic diseases of dogs are so diverse and so complex that it is not possible to adequately discuss them all in a letter. Thus, I believe that readers will be confused as to the main point of your letter.

For this reason, I have elected not to publish your letter. Please understand that this does not reflect a lack of concern about the topic, but simply my inability to understand what you are trying to convey to our readers.

Sincerely, Kurt J. Matushek, DVM, MS, DACVS
Interim Editor-in-Chief

Quando non pubblichi  una lettera di M.W.Fox vuol dire che siamo arrivati all’ammazza caffè!

References
(1) Sternbrook R. Controlling Conflict of Interest—Proposals from the Institute of Medicine. Published at www.nejm.org, April 29th 2009 (10. 1056/NEJMp0810200).

(2) Fox MW, Elizabeth Hodgkins and Marion E. Smart. Not fit for a dog: the truth about manufactured dog and cat food. Fresno, CA, Quill Driver Books, 2009.

(3) AVMA News. Topical flea and tick products come under EPA scrutiny. J Am Vet Med Assoc 2009; 234: 1228.

(4) AVMA News. AVMA enters into multimillion-dollar partnership with companies. J Am Vet Med Assoc 2008; 233: 219.

(5) Dodds WJ. Vaccination protocols for dogs predisposed to vaccine reactions. J Am Animal Hosp Assoc 2001; 38: 1-4.

(6) Schultz RD, Ford RB, Olsen J. and Scott F. Titer testing and vaccination: a new look at traditional practices. Vet Med, 2002, 97: 1-13 (insert).

(7) Hodgkins EM, Your Cat: Simple New Secrets to a Longer, Stronger Life,
New York, Thomas Dunne Books, 2007.

(8) Fox MW. Veterinary bioethics, pp 673-678, in Complementary and alternative medicine, Schoen AM and Wynn SG., eds., St Louis, MO, Mosby, 1998.

Michael W. Fox, BVetMed, PhD, DSc, MRCVS
Fox’s Pen Inc.
2135 Indiana Ave N., Golden Valley, Minnesota

 

​

​

​

bottom of page